Canine CEA antibody and antigen (recombinant protein)

Diagnostic anti-Canine CEA antibodies pairs and antigen for animal health (animal Dog/Canine breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-CAN-CEA-Ag01 Recombinant Canine CEA protein 3090
GMP-CAN-CEA-Ab01 Anti-Canine CEA mouse monoclonal antibody (mAb) 1953
GMP-CAN-CEA-Ab02 Anti-Canine CEA mouse monoclonal antibody (mAb) 1953
GMP-CAN-CEA-Ab03 Anti-Canine CEA human monoclonal antibody (mAb) 1953
GMP-CAN-CEA-Ab04 Anti-Canine CEA human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-CAN-CEA-Ag01
Product Name Recombinant Canine CEA protein
Target/Biomarker Canine carcinoembryonic antigen (AGP)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Canine carcinoembryonic antigen antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AGP level test of animal Dog/Canine with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer.
Tag His
Products description Recombinant Canine CEA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-CAN-CEA-Ab01, GMP-CAN-CEA-Ab02
Product Name Anti-Canine CEA mouse monoclonal antibody (mAb)
Target/Biomarker Canine carcinoembryonic antigen (AGP)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Canine carcinoembryonic antigen antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies in AGP level test of animal Dog/Canine with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer.
Tag mFc
Products description Anti-Canine CEA mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-CAN-CEA-Ab03, GMP-CAN-CEA-Ab04
Product Name Anti-Canine CEA human monoclonal antibody (mAb)
Target/Biomarker Canine carcinoembryonic antigen (AGP)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Canine carcinoembryonic antigen antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies in AGP level test of animal Dog/Canine with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer.
Tag hFc
Products description Anti-Canine CEA human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AGP antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Carcinoembryonic Antigen (CEA) in dogs (canines) is a glycoprotein biomarker that belongs to the immunoglobulin superfamily of cell adhesion molecules. This protein plays a multifaceted role in both normal physiology and disease states. During fetal development, CEA is actively produced and is involved in crucial cell adhesion processes, promoting tissue formation and integrity. However, in healthy adult dogs, CEA is typically present at very low levels. The structure of CEA is characterized by multiple immunoglobulin-like domains, making it adept at facilitating cell adhesion. Its primary function is to mediate interactions between cells, ensuring proper tissue organization during embryonic growth. In adult dogs, CEA's expression is significantly reduced but can become elevated in certain pathological conditions.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment